Beruflich Dokumente
Kultur Dokumente
RADIATION PROTECTION IN
DIAGNOSTIC AND
INTERVENTIONAL RADIOLOGY
L 3: Biological effects of ionizing radiation
IAEA
International Atomic Energy Agency
Introduction
Subject matter: radiobiology
The mechanisms of different types of
biological effects following exposure to
ionizing radiation
Types of models used to derive risk
coefficients for estimating the detriment
IAEA
Topics
Overview
To become familiar with the mechanisms of
different types of biological effects following
exposure to ionizing radiation. To be aware
of the models used to derive risk coefficients
for estimating the detriment.
IAEA
IAEA
International Atomic Energy Agency
CELL TRANSFORMATION
DETERMINISTIC
STOCHASTIC
Somatic
Clinically attributable
in the exposed
individual
IAEA
epidemiologically
attributable in large
populations
BOTH
ANTENATAL
somatic and
hereditary expressed
in the foetus, in the live
born or descendants
Stochastic
Cancer, genetic effects.
IAEA
Deterministic effects
Deterministic
(Threshold or nonstochastic)
Existence of a dose
threshold value (below
this dose, the effect is
not observable)
Severity of the effect
increases with dose
A large number of cells
are involved
IAEA
3.5-6 Gy
2.5-6 Gy
Severity of
effect
Temporary sterility
males
females
0.15 Gy
0.6 Gy
dose
threshold
IAEA
Stochastic Effects
Stochastic(Non-Threshold)
No threshold
Probability of the effect increases with dose
Generally occurs with a single cell
e.g., cancer, genetic effects
IAEA
10
No change
DNA mutation
radiation
hit cell
nucleus!
DIRECTACTION
ACTION
DIRECT
INDIRECT
INDIRECTACTION
ACTION
Viable Cell
Mutation
repaired
Cell death
Unviable Cell
Cancer ?
DNA Mutation
Cell survives
but mutated
DAMAGE TO DNA
DAMAGE
REPAIRED
IAEA
CELL DEATH
(APOPTOSIS)
TRANSFORMED
CELL
16
DAMAGE TO DNA
DAMAGE
REPAIRED
CELL
NECROSIS
TRANSFORMED
CELL
OR
APOPTOSIS
IAEA
17
How DNA is
repaired ?
Altered base
Enzyme Glycosylases recognizes
lesion and releases damaged base
AP-endunuclease makes incision
and releases remaining sugar
DNA-polymerase fills resulting gap
but nick remains
IAEA
20
ADAPTIVE
RESPONSE
Conditioning dose
Response
Challenging dose
Response
Conditioning dose
DAMAGE TO DNA
DAMAGE
REPAIRED
IAEA
CELL
NECROSIS OR
APOPTOSIS
TRANSFORMED
CELL
22
Normal human
lymphocyte:
chromosomes
uniformly
distributed
Apoptotic cell:
chromosomes
and nucleus
fragmented
and collapsed
into apoptotic
bodies
100%
Probability of cell
death
Acute dose
(in mSv)
IAEA
5000
3 : Biological effects of ionizing radiation
25
DAMAGE TO DNA
DAMAGE
REPAIRED
IAEA
CELL
NECROSIS OR
APOPTOSIS
TRANSFORMED
CELL
26
Chromosomal deletions
IAEA
27
Chromosomal translocations
IAEA
28
CANCER INITIATION
STEAM
CELL
TUMOR
PROMOTION
MALIGNANT
PROGRESSION
NECROSIS OR
APOPTOSIS
MUTATION
DIVISION
MALIGNANT
TRANSFOMATION
METASTASIS
NORMAL TISSUE
CELL INITIATION
An initiating event
creates a mutation in
one of the basal cells
DYSPLASIA
More mutations occurred.
The initiated cell has
gained proliferative
advantages.
Rapidly dividing cells
begin to accumulate
within the epithelium.
BENIGN TUMOR
More changes within
the proliferative cell
line lead to full tumor
development.
MALIGNANT TUMOR
The tumor breaks trough
the basal lamina.
The cells are irregularly
shaped and the cell line
is immortal. They have
an increased mobility
and invasiveness.
METASTASIS
Cancer cells break through
the wall of a lymphatic
vessel or blood capillary.
They can now migrate
throughout the body and
potentially seed new
tumors.
Energy deposition
10-15
Excitation/ionization
Initial particle tracks
10-9
Radical formation
TIME (sec)
10-12
PHYSICO-CHEMICAL INTERACTIONS
10-6
10-3
1 ms
100
1 second
Repair processes
Damage fixation
PHYSICAL INTERACTIONS
10
106
1 day Mutations/transformations/aberrations
Proliferation of "damaged" cells
1 year Promotion/completion
109
100 years
Timing of
events
leading to
radiation
effects.
BIOLOGICAL RESPONSE
Teratogenesis
MEDICAL EFFECTS
Cancer
Hereditary defects
IAEA
International Atomic Energy Agency
IAEA
40
Radiosensitivity (2)
High RS
Bone Marrow
Spleen
Thymus
Lymphatic
nodes
Gonads
Eye lens
Lymphocytes
Medium RS
Skin
Mesoderm
organs (liver,
heart, lungs)
Low RS
Muscle
Bones
Nervous
system
IAEA
41
Physical
LET (linear energy transfer): RS
Dose rate: RS
Chemical
% survivor cells
LET
LET
Biological
G0
M
Cycle status:
G2
RS: G2, M
RS: S
G1
IAEA
S
3 : Biological effects of ionizing radiation
42
IAEA
International Atomic Energy Agency
Systemic effects
Effects may be morphological and/or functional
Factors:
Which Organ
How much Dose
Effects
Immediate (usually reversible): < 6 months e.g.: inflammation,
bleeding.
Delayed (usually irreversible): > 6 months e.g.: atrophy,
sclerosis, fibrosis.
Categorization of dose
< 1 Gy: LOW DOSE
1-10 Gy: MODERATE DOSE
> 10 Gy: HIGH DOSE
Regeneration means replacement by the original tissue while
Repair means replacement by connective tissue.
IAEA
44
Skin effects
Following the RS laws (Bergonie and
Histologic view of the skin
EPIDERMIS
DERMIS
IAEA
about 3-5 Gy
Alopecia(*): 5 Gy is reversible; 20 Gy is
irreversible.
Pigmentation: Reversible, appears 8 days
after irradiation.
Dry or moist desquamation: traduces
epidermal hypoplasia (dose 20 Gy).
Delayed effects: teleangiectasia (**),
fibrosis.
45
Skin reactions
Injury
Early transient erythema
Temporary epilation
Main erythema
Permanent epilation
Dry desquamation
Invasive fibrosis
Dermal atrophy
Telangiectasis
Moist desquamation
Late erythema
Dermal necrosis
Secondary ulceration
IAEA
Threshold
Weeks to
Dose to
Onset
Skin (Sv)
2
3
6
7
10
10
11
12
15
15
18
20
<<1
3
1.5
3
4
>14
>52
4
6-10
>10
>6
Skin damage
from prolonged
fluoroscopic
exposure
46
Skin injuries
IAEA
47
Skin injuries
IAEA
48
Effects in eye
Histologic view of eye:
IAEA
Detectable
opacities
Visual
impairment
(cataract)
Sv single brief
exposure
Sv/year for
many years
0.5-2.0
> 0.1
5.0
> 0.15
49
Eye injuries
IAEA
50
IAEA
International Atomic Energy Agency
Steps:
10 - 50 Gy
Survival time
Chronic irradiation
syndrome
> 50 Gy
1. Prodromic
(onset of
disease)
2. Latency
3. Manifestation
BONE
MARROW
GASTRO
INTESTINA
L
CNS
Lethal dose 50 / 30
Mechanism:
Neurovegetative
disorder
Similar to a sick
feeling
Quite frequent in
fractionated
radiotherapy
(central nervous
system)
IAEA
Dose
3 : Biological effects of ionizing radiation
52
Lethal dose 50 / 30
Dose which would
cause death to 50% of
the population in 30
days.
Its value is about 2-3
Gy for humans for
whole body irradiation.
IAEA
53
IAEA
International Atomic Energy Agency
Congenital anomalies
Lethality
Pre-implantation
IAEA
Organogenesis
Foetus
Time
55
0.1 Gy
Lethality
Time
Pre-implantation
IAEA
Organogenesis
Foetus
56
IAEA
Severe mental
retardation with a
risk factor of
Severe mental
retardation with a
risk factor of
0.4/Sv
0.1/Sv
3 : Biological effects of ionizing radiation
57
IAEA
58
IAEA
International Atomic Energy Agency
Epidemiology I
Irradiated populations can be studied by
following cohorts of exposed and non-exposed
people
back-tracing patients suffering from the disease
with regard to possible exposure (case
controls)
IAEA
60
Epidemiology II
Irradiated populations are
people exposed from the atomic bomb
explosions
people exposed during nuclear and other
radiation accidents
patients exposed for medical reasons
people exposed to natural radiation
workers in radiation industries
IAEA
61
Epidemiology III
IAEA
62
Epidemiology IV
Information is scanty on:
Consequences of low doses delivered at low dose
rates
63
Epidemiology V
Modifying influence of cancer background
incidence
does radiation-induced cancer increase at a fixed level
or in proportion to existing cancer additive vs.
multiplicative risk model ?
64
REGION OF DETECTABILITY
Theoretical limit of detectability
due to statistical causes
(90% confidence interval)
10 3
10 2
101
CHERNOBYL
DOSES
10 0
10-1
10 0
REGION OF UNDETECTABILITY
101
10 2
10 3
10 4
105
106
107
108
109
10 10
1011
High
Male / Female
Nasopharynx
23.3
Esophagus
20.1
Stomach
95.5
Colon
35.0
Liver
46.7
Lung+Bronchus 110.8
Skin melanoma 33.1
Breast female
Cervix
from UNSCEAR 2000
IAEA
9.5
8.3
40.1
29.6
11.5
29.6
29.8
103.7
53.5
Low
Male /Female
0.2
0.5
5.2
1.8
0.7
10.3
0.2
0.1
0.2
2.2
1.3
0.3
2.4
0.2
14.6
3.0
66
Approximate Size
IAEA
67
68
69
10
5
2
1
0.5
IAEA
1950- 1955- 1959- 1963- 1967- 1971- 1975- 19791954 1958 1962 1966 1970 1974 1978 1982
71
Relative risk
1.5
0.6
0.5
0.4
0.3
0
IAEA
100
200
300
400
500
72
1
0
IAEA
73
Relative risk
Thyroid Cancer
6
4
2
0
0.05
0.1
Thyroid benign
tumors
0.15
0.2
0.25
74
80
No of Cases
Belarus
60
40
Ukraine
20
0
86
87
IAEA
Russian Fed.
88
89
90
91
92
93
94
95
96
97
98
75
No of Cases
before the accident after the accident
Belarus
(1977-1985) 7
(1986-1994) 390
Ukraine
(1981-1985) 24
(1986-1995) 220
Russia (Bryansk and Kaluga region only) (1986-1995) 62
The data represent incidences (not mortality) and are
preliminary results.
Most excess cancers occurred since 1993.
Thyroid cancer has a high rate of cure >90%, but many of the
cancers found are of the aggressive papillary type.
IAEA
76
UK National Registry
Radiation Workers
0.47 (-0.12-1.20) 4.3 (0.4-13.6)
1,218,000 person years
34 mSv average dose
US Workers
-1.0 (<0-0.83
<0 (<0-3.4)
705,000 person years
32 mSv average dose
Atomic Bomb Survivors 0.33 (0.11-0.6) 6.2 (2.7-13.8)
2,185,000 person years
251 mSv average dose
IAEA
77
X Ray
Abdomen
2.6
Barium enema
16
Barium meal
2.8
IV urography
3.2
Lumbar spine
3.2
Pelvis
1.7
Computed tomography
Abdomen
8.0
Lumbar spine
2.4
Pelvis
25
Nuclear medicine
Tc bone scan
3.3
Tc brain scan
4.3
IAEA
Fatal cancer
to age 14 y
6.2 10-5
3.9 10-4
6.7 10-5
7.7 10-5
7.6 10-5
4.0 10-5
7.7 10-5
4.8 10-4
8.4 10-5
9.6 10-5
9.5 10-5
5.1 10-5
1.9 10-4
5.7 10-5
6.1 10-4
2.4 10-4
7.1 10-5
7.7 10-4
7.9 10-4
1.0 10-5
1.0 10-4
1.3 10-4
78
15
55
IAEA
60
65
Age Years
70
75
79
IAEA
80
81
% Effect
probability
dose
IAEA
Dose
Risk =
factor
probability
dose
82
% Effect
IAEA
probability
dose
Dose
Risk
factor
probability
=
dose
83
IAEA
wT
0.20
0.12
0.12
0.12
0.12
0.05
0.05
0.05
0.05
0.05
0.01
0.01
0.05
3 : Biological effects of ionizing radiation
84
Summary
Effects of ionizing radiation may be
deterministic and stochastic, immediate or
delayed, somatic or genetic
Some tissues are highly radiosensitive
Each tissue has its own risk factor
Risk from exposure may be assessed
through such factors
IAEA
85
IAEA
86